Global Heart Blocks Treatment Devices Market Is Expected To Expand At A CAGR Of 5.9% During Forecast Period.

The global heart blocks treatment devices market captured a revenue growth of USD 2.89 billion in 2021 and is forecasted to reach around USD 4.26 billion by 2028, with a compound annual growth rate (CAGR) of approximately 5.9 percent over the forecast period. The condition known as heart block causes the heart to beat more slowly or with an irregular rhythm. It results from an issue with the electrical pulses that regulate the heartbeat. Treatment for heart block is often only necessary if symptoms are present. A person might need to have a tiny pacemaker implanted in the chest, depending on the reason for the heart block and the symptoms. A pacemaker is a tiny battery-powered device located under the skin of the chest. In order to maintain your heart pumping consistently, it frequently transmits electrical pulses.

The COVID-19 pandemic had a positive effect on the market for heart blockage treatment equipment. The prevalence of coronavirus is still rising globally, placing a major burden on the healthcare sector. Due to the increased likelihood that many individuals may contract COVID-19 during the pandemic period, there has been a substantial increase in cardiac patients and cardiovascular problems resulting in greater demand for cardiac treatment devices. However, because cardiac problems are becoming more common, it is anticipated that demand for heart block therapy devices will continue over the projected period.

The rapidly expanding prevalence of cardiovascular disease is one of the main factors fueling the growth and demand for heart block therapy devices. Moreover, the global heart blocks treatment devices market is expanding due to the rising senior population worldwide. The introduction of pacemakers and minimally invasive cardiovascular therapies, together with the continuously changing quality of life, are further factors influencing the market's growth. Additionally, the rise of the healthcare industry and hereditary disorders are both factors driving the market growth. The need for heart block treatment devices is also being supported by the increased prevalence of heart blockage occurrences as well as the rising prevalence of hypothyroidism, which commonly results in heart blocks.

The global heart block treatment devices market is categorized based on type, product type, end-user, and region. Based on type the market is segregated into first-degree heart block, second-degree heart block, and third-degree heart block. Among these types, second-degree heart block dominates the market with more than 45 percent of the share. Second-degree heart block is more common and requires immediate medical attention. Owing to this demand for heart block treatment devices is high in this type. The market is further categorized based on product type into transcutaneous pacing (TCP), mediation, pacemaker, and follow-up electrophysiology study. The end-user segment of the market is divided into hospital testing, clinics, home treatment, and others. The hospital segment dominates the market among other end users with nearly 40 percent of the market share.

North America is anticipated to represent a sizable portion of the global heart blocks treatment devices market in terms of revenue. Government assistance, an increase in heart block cases, rising R&D spending, and technological developments all account for a large share of the market. On the other side, the presence of the largest population with the highest unmet medical requirements, growing health care infrastructure, growth in treatment awareness, and the rise in disposable money make Asia Pacific the most promising region for the treatment of heart blocks. Furthermore, the markets in Africa and Latin America are still in their infancy. However, a lot of businesses are now concentrating on establishing and growing their clientele in the Middle Eastern nations as a result of infrastructural improvements in the healthcare sector.

Major players studied in the report for global heart blocks treatment devices market include Medtronic, Boston Scientific Corporation, MicroPort Scientific Corporation, Abbott, Stryker, Koninklijke Philips N.V., Lepu Medical Technology Co., Ltd., LivaNova PLC, McKesson Corporation, Cigna, SCHILLER, Osypka Medical GmbH, and Shree Pacetronix Ltd.

Recent Development:

• In January 2020, Medtronic plc MDT obtained FDA approval for Micra AV, the newest addition to the Micra device range and the smallest pacemaker with atrioventricular (AV) synchronization to date.
• In November 2021, for the Indian drug-eluting stent market, Purple MicroPort Cardiovascular Private Limited, a joint venture company of MicroPort Scientific Corporation (MicroPort®), formally launched the Firehawk IN™ Rapamycin Target Eluting Coronary Stent System (Firehawk IN™) for commercial sale.

Browse the full “Heart Blocks Treatment Devices Market By Type (First-Degree Heart Block, Second-Degree Heart Block, Third-Degree Heart Block), By Product Type (Transcutaneous Pacing, Pacemaker, Mediation, Follow-up Electrophysiology Study), By End User (Hospital Testing, Home Treatment, Clinics, Others), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/heart-blocks-treatment-devices-market

Global heart blocks treatment devices market is segmented as follows:

By Type

• First-Degree Heart Block
• Second-Degree Heart Block
• Third-Degree Heart Block

By Product Type

• Transcutaneous Pacing (TCP)
• Pacemaker
• Mediation
• Follow-up Electrophysiology Study

By End User

• Hospital Testing
• Home treatment
• Clinics
• Other

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com